Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida, USA.
Scheie Eye Institute, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Pediatr Dermatol. 2023 Nov-Dec;40(6):1015-1020. doi: 10.1111/pde.15424. Epub 2023 Sep 5.
BACKGROUND/OBJECTIVES: To understand the landscape of industry payments to pediatric dermatologists to foster transparency and identify potential disparities in funding.
Using the Centers for Medicare and Medicaid Services (CMS) Open Payments database, a national cross-sectional study was performed examining payments to pediatric dermatologists from 2015 to 2021.
Of the 147 pediatric dermatologists who received industry funding, 35 were male and 112 were female. $9 million in payments was amassed, with 10% of pediatric dermatologists accounting for 94% of total industry payments. Consulting was the most common service, with Pfizer Inc., Amgen Inc., and Regeneron Healthcare Solutions Inc. representing the top three companies. Mean payment was $143,836 for males and $35,943 for females (p < .001). Eight female and seven male pediatric dermatologists received payments in the top 10th percentile, with different average payment in this subgroup (females $447,588 vs. males $698,746, p = .03). 11 states did not have a pediatric dermatologist receiving industry payments, while California (19) and Texas (12) had the most.
There are approximately 400 board-certified pediatric dermatologists in the United States and fewer than 40% are receiving monetary compensation from private industry. A fraction of physicians accounted for a majority of total industry payments and industry payments to male pediatric dermatologists were higher despite nearly triple the number of female pediatric dermatologists. With the rise of valuable partnerships between healthcare and industry in modern medicine, the implications of geographic, gender, and financial disparity of industry payments in pediatric dermatology are worthy of further study.
背景/目的：了解行业向儿科皮肤科医生支付的款项情况，以提高透明度并确定资金方面的潜在差异。
利用医疗保险和医疗补助服务中心（CMS）的公开支付数据库，开展了一项全国性的横断面研究，调查了 2015 年至 2021 年期间向儿科皮肤科医生支付的款项。
在接受行业资助的 147 名儿科皮肤科医生中，有 35 名男性和 112 名女性。共获得 900 万美元的款项，其中 10%的儿科皮肤科医生获得了 94%的行业总付款。咨询是最常见的服务，辉瑞公司（Pfizer Inc.）、安进公司（Amgen Inc.）和再生元制药公司（Regeneron Healthcare Solutions Inc.）位列前三大公司。男性的平均支付金额为 143836 美元，女性为 35943 美元（p<0.001）。有 8 名女性和 7 名男性儿科皮肤科医生获得了前 10%的支付款项，而这一亚组的平均支付金额不同（女性为 447588 美元，男性为 698746 美元，p=0.03）。有 11 个州没有儿科皮肤科医生获得行业支付，而加利福尼亚州（19 人）和得克萨斯州（12 人）拥有最多的儿科皮肤科医生。
在美国，大约有 400 名经过董事会认证的儿科皮肤科医生，其中不到 40%的医生从私营企业获得金钱补偿。少数医生的收入占行业总支付的大部分，尽管女性儿科皮肤科医生的人数是男性的三倍，但男性儿科皮肤科医生的行业支付更高。随着现代医学中医疗保健和行业之间有价值的伙伴关系的兴起，儿科皮肤科医生的行业支付在地域、性别和财务方面的差异值得进一步研究。
